Skip to main content
SpringerLink
Log in

Gastrointestinal cancer

CDX2: prognostic marker for high-risk colon cancer

  • Research Highlight
  • Published:

From Nature Reviews Clinical Oncology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dalerba, P. et al. CDX2 as a prognostic biomarker in stage II and stage III colon cancer. N. Engl. J. Med. 374, 211–222 (2016)

    Article  CAS  Google Scholar 

Download references

Authors
  1. Lisa Hutchinson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hutchinson, L. CDX2: prognostic marker for high-risk colon cancer. Nat Rev Clin Oncol 13, 134–135 (2016). https://doi.org/10.1038/nrclinonc.2016.18

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrclinonc.2016.18

  • Springer Nature Limited

Search

Navigation